R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker

 R&D, Innovation Key to Success - Research Report on Varian Medical Systems,
 Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical,
                   Inc., and Thermo Fischer Scientific Inc.

PR Newswire

NEW YORK, February 25, 2013

NEW YORK, February 25, 2013 /PRNewswire/ --

Today, Investors Alliance announced new research reports highlighting Varian
Medical Systems, Inc. (NYSE: VAR), Boston Scientific Corporation (NYSE: BSX),
Stryker Corporation (NYSE: SYK), St. Jude Medical, Inc. (NYSE: STJ) and Thermo
Fischer Scientific Inc. (NYSE: TMO). Today's readers may access these reports
free of charge - including full price targets, industry analysis and analyst
ratings - via the links below.

Varian Medical Systems, Inc. Research Report

World leader in radiotherapy and radiosurgery, Varian Medical Systems, has
recently announced collaborating with key development agencies in Russia. This
is to encourage the country's top scientific heads and research institutes to
work on research and development proposals for programs aimed at advancing
radiotherapy technology. The program presents the Russian R&D community with
the opportunity to take a focused look at the needs of radiotherapy. "We
believe this will yield significant benefits to cancer patients not only in
Russia but throughout the world. Russia was the first country to put a man
into space and it has a deep, sophisticated technological base in radiation
technologies," says Scott Johnson, Varian's Senior Manager - Research
Collaborations. The company has contributed $50,000 for this venture, which
will be combined with other funds equaling $100K in prize money for the team
or teams with the best proposals. Varian has more than 30 medical linear
accelerators installed in Russian cancer clinics. The company currently
provides up to 20 new treatment systems each year to radiotherapy departments
in the country. The Full Research Report on Varian Medical Systems, Inc. -
including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investors-alliance.com/r/full_research_report/f40b_VAR]

--

Boston Scientific Corporation Research Report

Innovation is at the core of everything that they do at Boston Scientific. As
a developer, manufacturer and marketer of medical devices that are used in
interventional medical specialties, the company continues to seek ways to
grow. Despite a challenging 2012, CEO Mike Mahoney expects the market to
stabilize this year. With trends moving in the company's favor, such as an
expanding product line and strong emerging markets overseas, help offset
slower growth in the US and other advanced countries. Boston Scientific has
also been revamping both its management and commercial structure in response
to the changes that are changing the health care industry worldwide. The Full
Research Report on Boston Scientific Corporation - including full detailed
breakdown, analyst ratings and price targets - is available to download free
of charge at:
[http://www.investors-alliance.com/r/full_research_report/b465_BSX]

--

Stryker Corporation Research Report

Stryker dedicates itself to helping healthcare professionals do their jobs
more efficiently while enhancing patient care. It offers a diverse array of
innovative medical technologies, that include reconstructive, medical and
surgical, and neurotechnology and spine products to help people lead more
active and more satisfying lives. Its recent undertakings include the
development of smart beds. These beds communicate with health care
communications systems, leading to better monitoring and increased levels of
patient comfort during recovery. The Full Research Report on Stryker
Corporation - including full detailed breakdown, analyst ratings and price
targets - is available to download free of charge at:
[http://www.investors-alliance.com/r/full_research_report/8335_SYK]

--

St. Jude Medical, Inc. Research Report

EnligHTNment trail - a landmark study of renal denervation for reduction of
heart attack, stroke and death - was initiated by St. Jude Medical. This study
will examine whether renal denervation and medication can provide health
benefits to patients beyond lowering high blood pressure. "To date, the renal
denervation studies that have been conducted only looked at reducing blood
pressure in patients with uncontrolled or resistant hypertension," said
ProfessorMichael Bohm, director and chief of internal medicine and cardiology
at theUniversity of Saarlandin Homburg/Saar, Germany, a principal
investigator for the trial. The EnligHTNment trial will be an international,
multi-center, randomized, controlled study examining the safety and
effectiveness of renal denervation with the EnligHTN Renal Denervation System
in reducing risk of major cardiovascular events. The Full Research Report on
St. Jude Medical, Inc. - including full detailed breakdown, analyst ratings
and price targets - is available to download free of charge at:
[http://www.investors-alliance.com/r/full_research_report/d3fb_STJ]

--

Thermo Fischer Scientific Inc. Research Report

Thermo Fischer launches the SureTect PCR system - a system that delivers test
efficiencies for food safety laboratories that are testing for the most common
bacterial pathogens. This combines a real-time PCR instrument with bespoke
software and convenient pre-filled reagent components that together with a
single PCR protocol for a range of common targets and samples types, thus
streamlining the process. Results for all targets and matrix types can now be
obtained in less than 24 hours. This enables food testing labs an easy set-up
and result reading. The Full Research Report on Thermo Fischer Scientific Inc.
- including full detailed breakdown, analyst ratings and price targets - is
available to download free of charge at:
[http://www.investors-alliance.com/r/full_research_report/ce54_TMO]

--

Consider Investors Alliance

Tired of hearing about the latest, greatest trade opportunity... only to
realize that the ship has long sailed? You need a strong, informative
community in your arsenal. Join the group that has been consistently
identifying momentous situations as they develop - long before they become the
next top news on major financial networks.

Contact: Patricia Byers
Email: press@investors-alliance.com
Main: +1-408-745-7826

SOURCE Investors-Alliance
 
Press spacebar to pause and continue. Press esc to stop.